When was AccuRx founded?

AccuRx was founded in 2016 and raised its 1st funding round within a year of its incorporation.

Where is AccuRx located?

AccuRx is headquartered in London, United Kingdom. It is registered at 27 Downham Road, London, England, N1 5AA.

Which legal entities is AccuRx associated with?

AccuRx is associated with ACCURX LIMITED.

How many employees does AccuRx have?

As of Sep 30, 2026, the latest employee count at AccuRx is 282.

Is AccuRx a funded company?

AccuRx is a funded company, having raised a total of $50.2M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Sep 06, 2016.

How much is AccuRx worth?

The latest valuation of AccuRx is £***** as of Sep 13, 2021.

When was the latest funding round of AccuRx?

AccuRx's latest funding was a $***** Series B round on Sep 15, 2021, with participation from 5 investors.

What is the annual revenue of AccuRx?

Annual revenue of AccuRx is between £10M and £50M as on Jun 30, 2025

Where does AccuRx rank among its competitors?

AccuRx ranks 1st amongst 42 active competitors, of which 5 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Seegnal, which secured $1.34M in Aug, 2026.

Who are the top competitors of AccuRx?

AccuRx's top competitors include Pyrls, MedAware and Seegnal. Among them, Seegnal secured the most recent funding round in August, 2026.

AccuRx - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Platform to increase antibiotic prescribing accuracy in primary care. They are building smart guideline nudges into the workflow, then incorporating patient engagement tools for self-management, followed by data-driven decision support. It delivers patient-specific local and national prescribing guidelines to specific trigger points in the workflow.

Website: www.accurx.com/
Social
Registered Address: 27 Downham Road, London, England, N1 5AA

Key Metrics

Founded Year

2016

Location

London, United Kingdom

Stage

Series B

Total Funding

$50.2M in 4 rounds

Latest Funding Round

Series B, Sep 15, 2021, $*****

Post Money Valuation

£***** as on Sep 13, 2021

Investors

Atomico & 10 more

Ranked

1^st among 42 active competitors

Annual Revenue

£10M - £50M as on Jun 30, 2025

Employee Count

282 as on Sep 30, 2026

Similar Companies

Pyrls & 49 more

View AccuRx's full profile

AccuRx is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ACCURX LIMITED CIN: 10184077 , United Kingdom, Active	May 16, 2016	£10M - £50M (As on Jun 30, 2025)	25 (As on Jun 30, 2020)

AccuRx has raised a total funding of $50.2M over 4 rounds. Its first funding round was on Sep 06, 2016. Its latest funding round was a Series B round on Sep 15, 2021 for $*****. 5 investors participated in its latest round. AccuRx has 10 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of AccuRx:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 15, 2021	3168084	Series B	5869297	6791914	4986602	8527555
Feb 24, 2019	5571954	Series A	4031090	5424063	1512082	Entrepreneurs First & 2 more
Mar 17, 2017	1772892	Seed	8819694	4585020	Anvil Partners	1572392

Access funding benchmarks and valuations. Sign up today!

View details of AccuRx's funding rounds and investors

The founders of AccuRx is Jacob Haddad.

Here are the details of AccuRx's key team members:

Jacob Haddad: Co-Founder of AccuRx. They are also an angel investor in 1 startup and serve on the board of 1 company.
Contact Info: 1 email address

AccuRx's Board of Directors

AccuRx's board has 3 active members. Jacob Haddad, Irina Elena Haivas and Laurence Bargery are part of team.

Here is the list of AccuRx's board of directors:

Name	Type	Representing	Status	Duration
Jacob Haddad	Team	-	Current	10y 3m
Laurence Bargery	Team	-	Current	10y 3m
rvflkgm	Team	-	Current	8y 8m

View details of AccuRx's Founder profiles and Board Members

AccuRx's employee count trend

AccuRx has 282 employees as of Sep 26. Here is AccuRx's employee count trend over the years:

Uncover AccuRx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of AccuRx include Pyrls, MedAware and Seegnal. Here is the list of Top 10 competitors of AccuRx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AccuRx 2016, London (United Kingdom), Series B	Platform to increase antibiotic prescribing accuracy in primary care	$50.2M	Atomico, Lakestar & 9 others	66/100
2nd	Pyrls 2018, Minneapolis (United States), Seed	Cloud-based practical drug information platform for providers	$500K	Y Combinator, Coho	48/100
3rd	MedAware 2012, Stamford (United States), Series A	Provider of an AI based medication dosage and safety managing software for healthcare professionals	$12M	Dreamit, Yingcheng City Fubon Technology ... & 14 others	46/100
4th	Seegnal 2012, San Diego (United States), Late Stage	Provides AI and cloud-based clinical decision support platform for drug related problems	-	-	46/100
5th	Bainbridge Health 2016, Philadelphia (United States), Series A	Provider of a clinical intelligence data analytics platform to monitor patient safety and reduce medication errors	$9.7M	BioAdvance, Chestnut Street Ventures & 3 others	41/100
6th	Ameritox 1996, Baltimore (United States), Acquired	Cannabis news, trends, laws, and product reviews for enthusiasts	-	Silversmith Capital Partners, Sterling Partners ... & 7 others	39/100
7th	YouScript 2000, Seattle (United States), Acquired	Developer of clinical decision support analytics software	-	Springboard Enterprises, Cascadia Venture Forum	33/100
8th	Genelex 1987, Seattle (United States), Acquired	Provides DNA Drug Sensitivity tests	-	-	32/100
9th	Advera Health 2010, Santa Rosa (United States), Acquired	Provider of a SaaS based regulatory data analysis and pharmacovigilance platform for life science industry	$2.7M	Evaluate, Magnolia Ventures	32/100
10th	BetterFit Technologies 2011, Cambridge (United States), Deadpooled	Adaptive texting platform to monitor patient compliance and adverse reactions to drug therapy	$1.09M	Highland Capital Partners, Techstars & 1 others	29/100